Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Mr Sherif Nagueh
Imaging can be used to identify the presence as well as the extent of myocardial damage in patients with coronary artery disease (CAD). The presence of segmental dysfunction due to myocardial necrosis is readily examined by echocardiography. Most labs use a semiquantitative score and a 17 segment model. Left ventricular (LV) endocardial border visualization can be enhanced using intravenous contrast agents, if needed. In addition to looking at regional function at rest, the use of dobutamine echocardiography can help determine the presence of contractile reserve. In the absence of contractile reserve, there is a low likelihood of improvement in segmental function after revascularization. For global function to improve, the presence of at least 3-5 segments with a biphasic response (improvement of function at low dose with deterioration at high dose) is needed. Recent developments with 3D and myocardial strain have been applied to study cardiac function in patients with CAD. For example, the presence of reduced (less negative) longitudinal strain/strain rate and the occurrence of post-systolic deformation are characteristics of dysfunctional segments.
Cardiac magnetic resonance (CMR) is another modality that has been used for the same objectives as those outlined above for echocardiography. CMR detects and quantifies injured myocardium. It can quantify transient injury and can be used to derive the salvation index. CMR measurements of infarct size have been shown to predict outcomes in several patients groups, including those presenting with acute coronary syndromes and those with CAD and hibernating myocardium. There is growing interest in using T1 mapping to study myocardial damage, but additional studies are needed.
Both SPECT and PET have been used to diagnose myocardial ischemia and scarring, and thus to detect viability. The presence of viability using nuclear imaging techniques was shown to predict segmental and global recovery of function after revascularization. However, there is a discrepancy between observational studies and randomized clinical trials with respect to prognosis. The ESC guidelines for heart failure management published in 2012 recommend revascularization for heart failure patients with CAD and angina, but there is no clear recommendation for viability imaging in the absence of angina. The detection of myocardial denervation in the region of an MI is possible using I-123 MIBG and the extent of denervation has been shown to predict outcome, including risk of ventricular arrhythmias.
© 2017 European Society of Cardiology. All rights reserved